The forecasted import of insulin in dosage forms to Norway shows a sharp decline from 2024 to 2028. In 2023, the volume stood at a significantly higher level, but the decline begins sharply in 2024 from 12.21 thousand kilograms to just 0.80563 thousand kilograms by 2028.
Year-on-year variations indicate a downturn, with:- 2024 to 2025: -24.1%- 2025 to 2026: -31.1%- 2026 to 2027: -44.1%- 2027 to 2028: -77.4%
The compound annual growth rate (CAGR) over this five-year period is -48.8% per year, pointing to a significant reduction in imports on an annual basis.
Future trends to watch for include advancements in local production capacities, policy changes around import restrictions, and potential innovations in diabetes treatment that might reduce dependency on imported insulin.
